EGLN3 and breast carcinoma: As PHD3 has been shown to promote degradation of HIF-1α [27] and HIF-1α has been shown to play key roles in many crucial aspects of breast cancer biology, including invasion and metastasis [28], we hypothesized that HIF-1α could be a mediator of the invasive effects of ERβ2 in this system.